| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 27.086 | 22.495 | 29.758 | - | 18.398 | 18.427 | 19.998 |
| Total Income - EUR | - | - | - | 27.086 | 22.495 | 29.758 | - | 18.398 | 18.427 | 19.998 |
| Total Expenses - EUR | - | - | - | 890 | 14.357 | 11.970 | - | 4.032 | 16.738 | 14.925 |
| Gross Profit/Loss - EUR | - | - | - | 26.196 | 8.138 | 17.788 | - | 14.366 | 1.688 | 5.073 |
| Net Profit/Loss - EUR | - | - | - | 25.814 | 7.913 | 17.491 | - | 14.186 | 1.504 | 4.877 |
| Employees | - | - | - | 1 | 1 | 1 | - | 1 | 1 | 1 |
Check the financial reports for the company - Pap Smear Medical Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
| Current Assets | - | - | - | 27.088 | 36.662 | 54.918 | - | 16.281 | 4.193 | 8.440 |
| Inventories | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | - | 1.888 | 458 | 545 |
| Cash | - | - | - | 27.088 | 36.662 | 54.918 | - | 14.393 | 3.736 | 7.896 |
| Shareholders Funds | - | - | - | 25.857 | 33.269 | 50.129 | - | 14.337 | -534 | 4.347 |
| Social Capital | - | - | - | 43 | 42 | 41 | - | 41 | 40 | 40 |
| Debts | - | - | - | 1.231 | 3.393 | 4.789 | - | 1.943 | 4.727 | 4.094 |
| Income in Advance | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Pap Smear Medical Lab S.r.l.